Sonic hedgehog in normal and neoplastic proliferation: insight gained from human tumors and animal models

被引:110
作者
Wetmore, C
机构
[1] Mayo Clin, Dept Pediat & Adolescent Med, Div Pediat Hematol Oncol, Rochester, MN 55905 USA
[2] Mayo Clin, Program Neurooncol, Rochester, MN 55905 USA
关键词
D O I
10.1016/S0959-437X(03)00002-9
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cancer arises when a cell accumulates multiple genetic changes that allow it to elude the highly regulated balance between proliferation and apoptosis that an organism employs to suppress inappropriate growth. It has become evident that malignant transformation of a cell or group of cells often involves pathways that are active during normal development but are inappropriately regulated in neoplastic proliferation. Signaling via the Sonic hedgehog pathway is critical to vertebrate development and also appears to play an integral role in the initiation and propagation of some tumors of the muscle, skin and nervous system. Analyses of human tumors have revealed mutations in various components of the Sonic hedgehog signaling pathway that appear to result in the activation of this pathway, as inferred by the increased expression of the transcription factor, Gli1. Interestingly, a proportion of the human tumors and most of those arising in mouse models continue to express the normal Patched allele, suggesting the involvement of additional molecular events in the transformation of the haploinsufficient cells.
引用
收藏
页码:34 / 42
页数:9
相关论文
共 78 条
  • [61] Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine
    Taipale, J
    Chen, JK
    Cooper, MK
    Wang, BL
    Mann, RK
    Milenkovic, L
    Scott, MP
    Beachy, PA
    [J]. NATURE, 2000, 406 (6799) : 1005 - 1009
  • [62] Patched acts catalytically to suppress the activity of Smoothened
    Taipale, J
    Cooper, MK
    Maiti, T
    Beachy, PA
    [J]. NATURE, 2002, 418 (6900) : 892 - 897
  • [63] Mutations in SUFU predispose to medulloblastoma
    Taylor, MD
    Liu, L
    Raffel, C
    Hui, CC
    Mainprize, TG
    Zhang, XY
    Agatep, R
    Chiappa, S
    Gao, LZ
    Lowrance, A
    Hao, AH
    Goldstein, AM
    Stavrou, T
    Scherer, SW
    Dura, WT
    Wainwright, B
    Squire, JA
    Rutka, JT
    Hogg, D
    [J]. NATURE GENETICS, 2002, 31 (03) : 306 - 310
  • [64] Cancer Modeling in the modern era: Progress and challenges
    Van Dyke, T
    Jacks, T
    [J]. CELL, 2002, 108 (02) : 135 - 144
  • [65] Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation
    Venkatachalam, S
    Shi, YP
    Jones, SN
    Vogel, H
    Bradley, A
    Pinkel, D
    Donehower, LA
    [J]. EMBO JOURNAL, 1998, 17 (16) : 4657 - 4667
  • [66] Somatic mutations in the human homologue of Drosophila patched in primitive neuroectodermal tumours
    Vorechovsky, I
    Tingby, O
    Hartman, M
    Stromberg, B
    Nister, M
    Collins, VP
    Toftgard, R
    [J]. ONCOGENE, 1997, 15 (03) : 361 - 366
  • [67] Complications of the nevoid basal cell carcinoma syndrome: A case report
    Walter, AW
    Pivnick, EK
    Bale, AE
    Kun, LE
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1997, 19 (03) : 258 - 262
  • [68] The developmental biology of brain tumors
    Wechsler-Reya, R
    Scott, MP
    [J]. ANNUAL REVIEW OF NEUROSCIENCE, 2001, 24 : 385 - 428
  • [69] Control of neuronal precursor proliferation in the cerebellum by sonic hedgehog
    Wechsler-Reya, RJ
    Scott, MP
    [J]. NEURON, 1999, 22 (01) : 103 - 114
  • [70] Neuropathology of genetically engineered mice: Consensus report and recommendations from an international forum
    Weiss W.A.
    Israel M.
    Cobbs C.
    Holland E.
    James C.D.
    Louis D.N.
    Marks C.
    McClatchey A.I.
    Roberts T.
    Van Dyke T.
    Wetmore C.
    Chiu I.-M.
    Giovannini M.
    Guha A.
    Higgins R.J.
    Marino S.
    Radovanovic I.
    Reilly K.
    Aldape K.
    [J]. Oncogene, 2002, 21 (49) : 7453 - 7463